4//SEC Filing
Colangelo Dominick 4
Accession 0001140361-25-006085
CIK 0000887359other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:05 PM ET
Size
9.0 KB
Accession
0001140361-25-006085
Insider Transaction Report
Form 4
Vericel CorpVCEL
Colangelo Dominick
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-24+18,250→ 268,456 total - Exercise/Conversion
Restricted Stock Unit
2025-02-24+18,250→ 54,750 total→ Common Stock (18,250 underlying) - Tax Payment
Common Stock
2025-02-24$52.33/sh−8,459$442,659→ 259,997 total
Footnotes (6)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest in annual installments on February 22, 2026, February 22, 2027, and February 22, 2028, respectively.
- [F2]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F3]These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
- [F4]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F5]No expiration date for this type of award.
- [F6]The Fair Market Value of the vested derivative securities is $52.33 per share.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001313403
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:05 PM ET
- Size
- 9.0 KB